articleTop 10% cited

Prevalence and Treatment of Psoriasis in the United Kingdom

Archives of Dermatology · 2005 · Vol. 141(12) · pp. 1537–41

Joel M. Gelfand✉(University of Pennsylvania)Rachel Weinstein(University of Pennsylvania)Steven B. Porter(Philadelphia University)Andrea L. Neimann(Philadelphia University)Jesse A. Berlin(University of Pennsylvania)David J. Margolis(Philadelphia University)

View via DOI Publisher page

Abstract

The epidemiology of psoriasis in the General Practice Research Database population is similar to that of other epidemiologic studies of psoriasis performed in the United Kingdom, the United States, and other Western countries. Psoriasis carries a substantial burden given its high prevalence and its associated need for prescription therapy. Additional studies are necessary to determine why the prevalence of psoriasis increases more rapidly in female patients and to determine why the prevalence decreases in patients 70 years and older.

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Health Systems, Economic Evaluations, Quality of LifePsoriasisMedicineMedical prescriptionEpidemiologyPopulationGeneral practiceCohort studyCohortCross-sectional studyDermatology

MeSH terms

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCross-Sectional StudiesDermatologic AgentsFamily PracticeFemaleUnited KingdomHumansInfantInfant, NewbornMale

Citations

598

FWCI

5.67

field-weighted impact

References

Percentile

97%

vs. same field & year

Citations per year

Cited by

The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis